Evidence map›Paper›PMID 15795306›Full record

ArticleJournal of virology2005

Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1.

Prerana Jayakumar, Irina Berger, Frank Autschbach, Mark Weinstein, Benjamin Funke, Eric Verdin, Mark A Goldsmith, Oliver T Keppler

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Prerana JayakumarGladstone Institute of Virology and Immunology, San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA.
Irina Berger
Frank Autschbach
Mark Weinstein
Benjamin Funke
Eric Verdin
Mark A Goldsmith
Oliver T Keppler
Institute of Virology of the Slovak Academy of Sciences · SKTaipei Institute of Pathology · TWHeidelberg University · DESan Francisco General Hospital · US

Funding

HIV FITNESS, VIRULENCE AND EVOLUTIONR01CA086814 · NCI · J. DAVID GLADSTONE INSTITUTES · PI GREENE, WARNER C · 2000 to 2003
$1.1M
HIV CORECEPTORS--FUNCTION, SPECIFICITY AND PATHOGENESISR01AI043695 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI GOLDSMITH, MARK A · 1999 to 2001
$570k
NCI NIH HHS CA86814NIAID NIH HHS AI43695
6 · The paper itself

Abstract

Infection of macrophages has been implicated as a critical event in the transmission and persistence of human immunodeficiency virus type 1 (HIV-1). Here, we explore whether primary X4 HIV-1 isolates can productively infect tissue macrophages that have terminally differentiated in vivo. Using immunohistochemistry, HIV-1 RNA in situ hybridization, and confocal immunofluorescence microscopy, we demonstrate that macrophages residing in human tonsil blocks can be productively infected ex vivo by primary X4 HIV-1 isolates. This challenges the model in which macrophage tropism is a key determinant of the selective transmission of R5 HIV-1 strains. Infection of tissue macrophages by X4 HIV-1 may be highly relevant in vivo and contribute to key events in HIV-1 pathogenesis.

Indexed as

Antigens, CDCells, CulturedHIV-1HumansMacrophagesMicroscopy, ConfocalMonocytesAntigens, CD

Identifiers

PMID15795306
PMCPMC1069582
OpenAlexW2152922582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.